Clinical Trial Update: A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting

View source ↗

Summary

Pfizer is conducting a real-world study to learn how the 20-valent pneumococcal conjugate vaccine works in preventing pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Prevnar 20 (20-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumonia | Status: RECRUITING